Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.

Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase.

Patnaik S., Stevens K.L., Gerding R., Deanda F., Shotwell J.B., Tang J., Hamajima T., Nakamura H., Leesnitzer M.A., Hassell A.M., Shewchuck L.M., Kumar R., Lei H., Chamberlain S.D.

Exploration of the SAR around a series of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines led to the discovery of novel pyrrolopyridine inhibitors of the IGF-1R tyrosine kinase. Several compounds demonstrated nanomolar potency in enzyme and cellular mechanistic assays.

Bioorg. Med. Chem. Lett. 19:3136-3140(2009) [PubMed] [Europe PMC]

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health